Rethinking Sepsis: From Concepts to Syndromes to Diseases John C. Marshall OriginalPaper Pages: 5 - 10
An Analysis of Clinical Trials of Mediator-Specific Anti-Inflammatory Agents Jonathan E. SevranskyCharles Natanson OriginalPaper Pages: 11 - 19
An Historical Review of Glucocorticoid Treatment in Sepsis. Disease Pathophysiology and the Design of Treatment Investigation G. Umberto Meduri OriginalPaper Pages: 21 - 38
Anti-Endotoxin Antibodies in Sepsis: A Critical Evaluation Martin LlewelynJonathan Cohen OriginalPaper Pages: 39 - 45
The Microbial Aspects of Sepsis: Does the Organism and Its Treatment Affect Outcome? Steven Michael OpalDavid L. Horn OriginalPaper Pages: 51 - 55
IL-6 as a Marker of Excessive TNF-α Activity in Sepsis Edward A. PanacekMartin Kaul OriginalPaper Pages: 65 - 73